Video is loading...
Hope is on the Horizon for Pancreatic Cancer Patients
Milind Javle, M.D., associate professor in the Department of Gastrointestinal Medical Oncology at MD Anderson Cancer Center, is offering hope for those faced with pancreatic cancer. Javle is leading a new clinical trial which targets the rapid growth of pancreatic cancer cells. This trial is testing the standard treatment with a new antibody that has shown promising results in the laboratory.
Title: Hope is on the Horizon for Pancreatic Cancer Patients
Summary: Milind Javle, M.D., associate professor in the Department of Gastrointestinal Medical Oncology at MD Anderson Cancer Center, is offering hope for those faced with pancreatic cancer. Javle is leading a new clinical trial which targets the rapid growth of pancreatic cancer cells. This trial is testing the standard treatment with a new antibody that has shown promising results in the laboratory.
Keywords: Pancreatic, cancer, pancreas, md Anderson, javle, hope, clinical trial, Milind Javle, pancreatic cancer, research, cancerwise
Transcript: